Andere Sprachen Orion Pharma Limited

Aktien

ORIONPHARM

BD0486OPL004

ORIONPHARM

Schlusskurs Dhaka S.E. Andere Börsenplätze 00:00:00 25.04.2024			% 5 Tage	% 1. Jan.
62,8 ^BDT	-2,94 %		-2,48 %	-21,11 %

04.02.	Orion Pharma Limited meldet Gewinnergebnisse für das zweite Quartal und die sechs Monate bis zum 31. Dezember 2023	CI
2023	Orion Pharma Limited meldet Ergebnis für das erste Quartal bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Orion Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	04.02.
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2023	15.11.
Orion Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023	03.05.23
Orion Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022	12.02.23
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2022	20.11.22
Orion Pharma Limited Recommends Cash Dividend for the Year Ended June 30, 2022	14.11.22
Orion Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022	27.04.22
Orion Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021	30.01.22
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2021	15.11.21
40 femmes d’affaires qui comptent en Europe	25.02.21
Orion Pharma Limited Reports Earnings Results for the Second Quarter Ended December 31, 2020	01.02.21
Orion Pharma Limited Recommends Cash Divided for the Year Ended on June 30, 2020	09.11.20
Tenax Therapeutics : Gains North American Rights to Oral Levosimendan through Expanded License Agreement with Orion Corporation	16.10.20
Orion Pharma Limited Reports Earnings Results for the Third Quarter Ended March 31, 2020	20.05.20
Orion Pharma Limited Appoints Zareen Karim as Managing Director	09.01.20
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2019	13.11.19
Orion Pharma Limited Recommends Cash Dividend for the Year Ended on June 30, 2019	07.11.19
Orion Pharma Limited Reports Earnings Results for the Third Quarter Ended March 31, 2019	07.05.19
Orion Pharma Limited Reports Earnings Results for the Second Quarter Ended December 31, 2018	05.02.19
Orion Pharma Limited Reports Earnings Results for the First Quarter Ended September 30, 2018	15.11.18

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Orion Pharma Limited

Aktien

ORIONPHARM

BD0486OPL004

ORIONPHARM

Andere Sprachen

Filter